Harmony Biosciences Holdings, Inc.
Support and Resistance Levels
Past performance
News About HRMY
All events for HRMY
All deals for HRMY
Financial Ratios
Financial Statements
HRMY vs Sector & Peers
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania. Website harmonybiosciences.com
Headquarters Plymouth Meeting, PA, US